register

News & Trends - MedTech & Diagnostics

Victorian-first procedure a new alternative for patients with atrial fibrillation

Health Industry Hub | October 12, 2022 |

MedTech News: Australians suffering from atrial fibrillation – the most common type of irregular heartbeat – have access to two new procedures designed to effectively treat the chronic heart condition at Peninsula Private Hospital, a Ramsay Health Care hospital.

Peninsula Private recently became the first hospital in the country to offer Totally Thoracoscopic Maze (TTM) with 50 patients so far receiving the potentially life-saving surgery. Now, the hospital is set to introduce the Convergent Cardiac Procedure, which also targets atrial fibrillation, for the first time in Victoria.    

It is estimated that more than half a million Australians suffer from atrial fibrillation, which if left untreated can lead to stroke or heart failure.  

Cardiothoracic Surgeon, Dr Adrian Pick, said these procedures were a new alternative for approximately 50% of atrial fibrillation sufferers who were previously told their condition was untreatable. 

“Patients with atrial fibrillation who are not suitable for surgery are treated with anti-arrhythmic and anti-coagulation medications, both of which carry with them considerable potential side effects,” Dr Pick said. 

“These new ‘hybrid’ procedures use a minimally invasive approach, as opposed to open surgery. Via the small incisions, targeted heat called radio frequency ablation is used to create lesions across the  pulmonary veins together with either interconnecting roof and floor lines or ablation of the entire posterior wall of the left atrium. The left auricular appendage of the heart is then clamped with special device called an Atriclip. The procedure is designed to eliminate abnormal electrical impulses and restore the patient to sinus rhythm.”

AA-Med is the sponsor for Atriclip in Australia. The device is manufactured by Atricure.

Dr Pick has been refining techniques for minimally invasive Aortic, Mitral and Thoracic surgery for more than 20 years. 

Peninsula Private Hospital CEO, Michelle Henderson, said she was proud the hospital could bring these leading procedures to Victoria. 

“These procedures are increasingly being used in the northern hemisphere to treat atrial fibrillation, and we’re pleased to be able to offer then here at Peninsula Private Hospital,” Ms Henderson said. 

“These procedures will offer new hope to many living with chronic cardiac arrythmias. Ramsay Health Care is committed to investing in new technology and new procedures to offer the best care for patients.” 

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Horizon Scanning Report Reveals Systemic Gap

Horizon scanning report exposes critical systemic gaps demanding immediate reform

Health Industry Hub | November 15, 2024 |

Medicines Australia has released the report from its 2024 Horizon Scanning Forum, a cornerstone of its Strategic Agreement with the […]

More


News & Trends - Pharmaceuticals

Is the NHS decline a warning for Australia's healthcare system?

Is the NHS decline a warning for Australia’s healthcare system?

Health Industry Hub | November 15, 2024 |

A decline in the performance of England’s National Health Service (NHS) offers important insights for Australia and other nations that […]

More


News & Trends - MedTech & Diagnostics

NSW’s first integrated care centre for prostate cancer patients sets new standard

NSW’s first integrated care centre for prostate cancer patients sets new standard

Health Industry Hub | November 15, 2024 |

In a NSW-first, a centre dedicated to the comprehensive treatment of prostate cancer, offering free, integrated care for both public […]

More


News & Trends - MedTech & Diagnostics

Medtronic and Abbott compete for leadership in next-gen leadless pacemakers

Medtronic and Abbott compete for leadership in next-gen leadless pacemakers

Health Industry Hub | November 15, 2024 |

Medtronic is advancing its leadless pacemaker technology with the release of the Micra VR2 and Micra AV2, highlighting new features […]

More


This content is copyright protected. Please subscribe to gain access.